Converse evidence suggests that TRAF4, but not Skp2, is required for AKT K63 ubiquitination and promotes EGF-induced AKT membrane recruitment in human lung cancer cells to induce tumorigenic properties [60], but TRAF6 is unnecessary for EGF-induced AKT activation [59, 60]. This evidence concerns the gene EGF and lung cancer.